AASM Accredits 1,000th Facility

On Friday, the American Academy of Sleep Medicine (AASM) announced on its Web site that the Sleep Center at St. Lukes Medical Center Kirby Glen in Houston, Tex, has just become its 1,000th accredited facility.

RPSGT Applications Up 46%

More sleep medicine technicians are taking and passing the exam to become registered polysomnographic technologists (RPSGTs), said the Board of Registered Polysomnographic Technicians (BRPT), which administers the exam.

Driver with Sleep Apnea Hits Teens

One New York state teenager was killed and another injured when a man with sleep apnea fell asleep behind the wheel of his Hummer and hit the girls, Suffolk County, NY, police said in a story reported in Newsday.

FDA Deepens Review of New Insomnia Drug

Based on a request from the Food and Drug Administration (FDA), Somaxon Pharmaceuticals, San Diego, is updating information regarding the preclinical testing of SILENOR™, a drug candidate for the treatment of insomnia.

New Data Support Long-Term Use of AMBIEN CR

A new study of AMBIEN CR, a controlled-release formula prescription sleep medication approved by the Food and Drug Administration (FDA) for sleep maintenance and sleep induction, found that the drug demonstrated significant improvements in total sleep time (TST), sleep onset latency (SOL), wake time after sleep onset (WASO), sleep quality, and number of awakenings versus placebo.

Rozerem Launches Direct-to-Consumer Campaign

Physicians who treat insomnia may soon find their patients asking for a new medication. After a year of marketing the insomnia medication Rozerem to physicians, the drug maker Takeda Pharmaceuticals North America, Lincolnshire, Ill, is taking its message direct to consumers with an advertising campaign launching today.